The Valley Desk

NCT06395519 · Interventional trial

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Advanced or Metastatic Solid Tumors, BRCA Mutation, BRCA1 Mutation, BRCA2 Mutation, Breast Cancer, Castrate Resistant Prostate Cancer, Colorectal Cancer, ER+ Breast Cancer, Endometrial Cancer, Epithelial Ovarian Cancer, Gastric Cancer, Ovarian Cancer, Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov